German CDMO BioSpring is building a new production facility that it hopes will become one of the world's biggest manufacturing sites for DNA- and RNA-based active pharmaceutical ingredients (API). The ...
Hosted on MSN
Indian pharma eyes Russian market: Firms explore localised production; target to build largest API hub
"India supplies a significant share of generics and active pharmaceutical ingredients (API) to Russia, and we plan to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback